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2022 Twenty-year experience with the St Jude Medical mechanical valve
prosthesis
John S. Ikonomidis, MD, PhD, John M. Kratz, MD, Arthur J. Crumbley III, MD,
Martha R. Stroud, MS, Scott M. Bradley, MD, Robert M. Sade, MD, and
Fred A. Crawford, Jr, MD, Charleston, SC
A total of 837 recipients of St Jude Medical mechanical valves (AVR, n  478; MVR, n 
359) from January 1979 to December 2000 were followed prospectively at 12-month intervals.
After 2 decades of observation with close follow-up, the St Jude Medical mechanical valve
continues to be a reliable prosthesis.
2032 Gender and outcomes after coronary artery bypass grafting: A propensity-
matched comparison }
Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Nancy Nussmeier, MD, and
Eugene H. Blackstone, MD, Cleveland, Ohio, and Houston, Tex
Gender differences in preoperative profiles were so dissimilar that only 26% of the women
could be matched on propensity scores with men. On the basis of propensity-matched pairs,
female gender is not a risk factor for mortality and has minimal impact on morbidity after
coronary artery bypass grafting.
2044 Gender profiling in coronary artery bypass grafting }
Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Nancy Nussmeier, MD, and
Eugene H. Blackstone, MD, Cleveland, Ohio, and Houston, Tex
The reported increased risk of poor outcome after coronary artery bypass grafting in women
compared with men may simply reflect a difference in the risk profile. Eighteen variables were





2052 Pentoxifylline is as effective as leukocyte depletion for modulating
pulmonary reperfusion injury
Stephen C. Clark, FRCS(C/Th), Jagan N. Rao, FRCS, Paul A. Flecknell, MRCVS, and
John H. Dark, FRCS, Newcastle upon Tyne, United Kingdom
Pentoxifylline and initial extracorporeal perfusion through a leukocyte-depleting filter were
directly compared in a porcine model of single-lung transplantation. Pentoxifylline was as
effective as leukocyte depletion in ameliorating reperfusion injury and represents a simple and
effective method of ameliorating reperfusion injury without the need for complex
extracorporeal systems.
2058 Rapamycin has no effect on fibrosis-associated gene expression or
extracellular matrix accumulation when administered to animals with
established or early allograft vasculopathy
Gavin J. Murphy, FRCS, and Michael L. Nicholson, MD, FRCS, Leicester, United Kingdom
This study demonstrates that in F344 to LEW allografts, rapamycin has no effect on the
progression of early or established allograft vasculopathy with regard to intimal thickening,
remodeling, extracellular matrix accumulation, or profibrotic gene expression.
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